DARS Antikörper (AA 9-331) (FITC)
Kurzübersicht für DARS Antikörper (AA 9-331) (FITC) (ABIN7970419)
Target
Alle DARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 9-331
-
Verwendungszweck
- Anti-DARS1 Antibody FITC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human DARS1 recombinant protein (Position: K9-Q331).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human ELISA, 0.1-0.5 μg/mL
-
Kommentare
-
Applications are recommended based on the unconjugated antibody.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- DARS (Aspartyl-tRNA Synthetase (DARS))
-
Andere Bezeichnung
- DARS1
-
Hintergrund
-
Background: This gene encodes a member of a multienzyme complex that functions in mediating the attachment of amino acids to their cognate tRNAs. The encoded protein ligates L-aspartate to tRNA(Asp). Mutations in this gene have been found in patients showing hypomyelination with brainstem and spinal cord involvement and leg spasticity. Alternative splicing results in multiple transcript variants.
Gene Full Name: aspartyl-tRNA synthetase 1
-
Gen-ID
- 1615
-
UniProt
- P14868
Target
-